CCM
MGNX icon

Coldstream Capital Management’s MacroGenics MGNX Stock Holding History

Coldstream Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-503
Closed -$639 – 2417
2025
Q1 		$639 Buy
+503
New +$1.31K ﹤0.01% 3288

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Coldstream Capital Management's MGNX Position: Q2 2025 in Review

Coldstream Capital Management sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 503 shares — an estimated $639 sold.

Coldstream Capital Management first reported a position in MGNX in Q1 2025 and held it in 1 quarter. The position peaked at $639 in Q1 2025. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

  • Coldstream Capital Management reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 503 MacroGenics shares in Q2 2025, an estimated $639.
  • Coldstream Capital Management first reported a position in MacroGenics in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's MacroGenics position peaked at $639 in Q1 2025.
  • 112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.